iBio (IBIO) Work In Process (2016 - 2022)
iBio (IBIO) posted quarterly Work In Process of $4000.0 for Q2 2022, down 85.19% year-over-year from $27000.0 in Q2 2021, and down 87.1% quarter-over-quarter from $31000.0 in Q4 2021.
iBio (IBIO) Work In Process (2016 - 2022) Analysis & Trends
iBio (IBIO) has reported Work In Process for 5 consecutive years, with $4000.0 the latest figure, recorded in Q2 2022.
- In Q2 2022, Work In Process fell 85.19% year-over-year to $4000.0; the TTM figure through Jun 2022 stood at $4000.0 (down 85.19% YoY), while the FY2022 annual figure was $4000.0, down 85.19% from the prior year.
- Work In Process fell to $4000.0 in Q2 2022 per IBIO's latest filing, from $31000.0 in the prior quarter.
- Across five years, Work In Process topped out at $1.1 million in Q4 2020 and bottomed at $4000.0 in Q2 2022.
- Historically, Work In Process has averaged $407875.0 across 3 years, with a median of $244500.0 in 2021.
- Annual changes were most pronounced in 2021 — Work In Process slumped 97.11% — and 2022, when it slumped 85.19%.
- iBio's Work In Process stood at $1.1 million in 2020, then plunged by 97.11% to $31000.0 in 2021, then sank by 87.1% to $4000.0 in 2022.
- Business Quant data shows IBIO's Work In Process at $4000.0 in Q2 2022, $31000.0 in Q4 2021, and $57000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | iBio | 175.21 Mn | 175.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 4,000.00 |
| Dec 31, 2021 | 31,000.00 |
| Sep 30, 2021 | 57,000.00 |
| Jun 30, 2021 | 27,000.00 |
| Mar 31, 2021 | 432,000.00 |
| Dec 31, 2020 | 1.07 Mn |
| Sep 30, 2020 | 843,000.00 |
| Jun 30, 2020 | 798,000.00 |
| Jun 30, 2017 | 26,000.00 |
| Mar 31, 2017 | 60,000.00 |
| Dec 31, 2016 | 27,000.00 |
| Jun 30, 2016 | 22,000.00 |
| Mar 31, 2016 | 58,000.00 |